Overall, the results indicate that elderly women (≥ 70 years) show a higher frequency of ER positive and HER2-negative carcinomas, whereas those under 50 years tended to have ER negative and HER2-positive carcinomas, underscoring the higher frequency of more aggressive breast carcinomas in the younger age group. The gene discussed is ESR1; the disease is carcinoma.